Docetaxel and adjuvant treatment of breast cancer.
In women with node-negative breast cancer, replacing fluorouracil with docetaxel in the adjuvant chemotherapy protocol did not improve efficacy but in one trial led to a 5-fold increase in serious adverse effects.